Synmosa Biopharma Corporation (TPEX: 4114)
Health Care · Pharmaceuticals · TW
NT$30.15
+2.73% today · -5.4% 1Y
Synmosa Biopharma Corporation (TPEX: 4114) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $510.24M and employs 495 people.
Over the last twelve months the share price has lost 5.4%, trading between 27.55 and 32.41.
Tweenvest scores Synmosa Biopharma Corporation across four factors: quality 74/100, value 47/100, growth 75/100, dividend 76/100. Its strongest factor is dividend.
4114 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $510.24M
- Revenue (TTM)
- $209.93M
- P/E
- 19.73
- EPS
- 1.53
- Dividend yield
- 2.61%
- Beta (5Y)
- -0.01
- 52-week high
- NT$32.41
- 52-week low
- NT$27.55
- Avg volume (3M)
- —
- Shares outstanding
- 541.12M
- Employees
- 495
- Next earnings
- —
About Synmosa Biopharma Corporation
Synmosa Biopharma Corporation, established in Taipei, Taiwan, in 1980, operates as a dedicated specialty pharmaceutical enterprise. The company manages the entire lifecycle of pharmaceutical and healthcare products, from research and development to manufacturing, marketing, and distribution, primarily serving the Taiwanese market under its proprietary Synmosa brand. Its diverse product portfolio addresses key therapeutic categories, including cardiovascular health, respiratory conditions, urology, sex hormone treatments, and oncology. These offerings are available in various formats such as effervescent tablets, granules, nasal sprays, metered-dose inhalers, hormonal preparations, and other specialized forms. Beyond its proprietary products, Synmosa also extends its expertise through contract manufacturing services. The company maintains a significant international presence, exporting its goods to numerous countries including South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua.
- ISIN
- TW0004114004
- Founded
- 1959
- Listed since
- Dec 31, 2007
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shandong Sinobioway Biomedicine Co., Ltd.SZSE: 002581 | $516.12M | CN¥5.24 | +2.75% |
| Orchid Pharma LimitedNSEI: ORCHPHARMA | $515.65M | Rs983.95 | -0.61% |
| Oculis Holding AGNasdaqGM: OCS | $514.85M | $8.34 | -3.70% |
| Evolus, Inc.NasdaqGM: EOLS | $510.57M | $7.73 | -0.90% |
| Shanghai Shen Lian Biomedical CorporationSHSE: 688098 | $510.08M | CN¥8.32 | -1.65% |
| Shaanxi Kanghui Pharmaceutical Co., Ltd.SHSE: 603139 | $507.15M | CN¥34.01 | -0.50% |
| PKU HealthCare Corp.,Ltd.SZSE: 000788 | $504.51M | CN¥5.67 | +3.85% |
| Contineum Therapeutics, Inc.NasdaqGS: CTNM | $503.37M | $13.38 | +1.52% |
Figures last refreshed Oct 11, 2026.